Loading Events

« All Events

Updated Guidance for Using Intravenous Artesunate to Treat Severe Malaria in the United States

December 10 @ 2:00 pm - 3:00 pm EST

In the United States, about 2,000 cases of malaria are imported each year, 300 of which are severe. There is no FDA-approved drug available to treat severe malaria. Intravenous (IV) artesunate, which is neither FDA-approved nor commercially available, is currently the first-line drug to treat severe malaria in the United States. Since April 1, 2019, all U.S. clinicians must call the CDC to obtain IV artesunate to treat cases of severe malaria.
During this COCA Call, clinicians will learn about CDC’s updated guidance for using IV artesunate—a life-saving drug—to treat patients with severe malaria in the United States, and will receive an update on CDC’s artesunate program.
Please note: The slides for this presentation will be posted on the call page under the “Call Materials” tab.
If you are unable to attend this live COCA Call, the closed captioned video will be available to view on-demand on the call page a few days after the call.
Free continuing education (CE) is available for this COCA Call. Please see below for instructions on how to receive CE.
Activity-specific Objectives
At the conclusion of the session, the participant will be able to accomplish the following:

  1. Identify the criteria for severe malaria.
  2. Describe how to obtain IV artesunate from CDC.
  3. Explain the treatment of severe malaria, including interim treatment and the use of IV artesunate.

Discuss the impact of the National Artesunate for Severe Malaria Program on the treatment of severe malaria in the United States.
COCA Call Objectives
At the conclusion of the session, the participant will be able to accomplish the following:

  1. Cite background information on the topic covered during the presentation.
  2. Discuss CDC’s role in the topic covered during the presentation.
  3. Describe the topic’s implications for clinicians.
  4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.

Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of health care providers.

Read More »

Details

Date:
December 10
Time:
2:00 pm - 3:00 pm

Venue

Online Webinar

Organizer

CDC Clinician Outreach and Communication Activity